Mahindra & Mahindra Rights Issue 2025 Details, Record Date, Issue Price

Mahindra & Mahindra Rights Issue details are now available. The firm plans to issue 15,44,41,240 equity shares amounting to Rs 2,996.16 crores. Mahindra & Mahindra Rights issue price is Rs 194 per share, and the face value is Rs 2 per share.

Mahindra & Mahindra Rights Issue open date is May 22, 2025, and the close date is June 6, 2025. Mahindra & Mahindra's rights issue entitlement ratio is 1:8, which is 1 Rights Equity Shares for every 8 fully paid-up Equity Shares held on the record date.

Mahindra & Mahindra Rights Issue record date is May 14, 2025. The last date to buy shares of Mahindra & Mahindra is May 13, 2025. Rights Issue subscription status will be available after the issue goes live.

Mahindra & Mahindra Rights Issue Allotment date is June 9 2025, and the listing date is June 11, 2025. However, the listing will be on the BSE and NSE platforms.

Mahindra & Mahindra Limited's registrar is Kfin Technologies Limited, and the book-running lead manager(s) for this rights issue has not yet been disclosed.

Also Read | Bannari Amman Spinning Mills Rights Issue 2025 Details, Record Date, Issue Price

Mahindra & Mahindra Rights Issue Details

Mahindra & Mahindra Rights Issue details are as follows: the company plans to issue 15,44,41,240 equity shares, aggregating the amount of Rs 2,996.16 crores. Mahindra & Mahindra Rights issue price is Rs 194 per share. The rights issue entitlement ratio is 1:8, which is 1 Rights Equity Shares for every 8 fully paid-up equity share(s).

Mahindra & Mahindra Rights Issue Dates

Mahindra & Mahindra Rights issue record date is May 14, 2025, and the last date to buy shares of Mahindra & Mahindra is May 13, 2025.

Mahindra & Mahindra Rights Issue Subscription

Mahindra & Mahindra Rights Issue subscription status will be available after the issue goes live. The details of Rights Issue entitlement are 1 Rights Equity Share(s) for every 8 fully paid-up Equity Share(s) held on Record Date. Mahindra & Mahindra issue price is Rs 194 per share.

Mahindra & Mahindra Limited: About the Company

Accretion Pharmaceuticals Limited, established in 2012 in Ahmedabad, Gujarat, began as a partnership with a vision to deliver healthcare products of international quality at competitive prices. In 2023, the company transitioned into a limited entity, marking a significant milestone in its growth journey. Today, Accretion is a conglomerate comprising four robust companies and a dedicated team of over 400 professionals. The company’s WHO-cGMP and GLP-certified manufacturing facilities enable the production of a diverse portfolio, including tablets, capsules, oral liquids, topical preparations, and oral powders. Accretion operates in more than 30 countries, continually expanding its global footprint while upholding its core philosophy of “Growing Together”-fostering collaborative relationships with employees, customers, and partners. Driven by a commitment to quality, innovation, and accessibility, Accretion Pharmaceuticals Limited aims to empower healthier lives and shape the future of healthcare with a focus on Ayurveda, nutraceuticals, and pharmaceutical solutions.

Mahindra & Mahindra Limited Financials (Amount in Rs crore)

Mahindra & Mahindra Rights Issue Registrar

Mahindra & Mahindra Limited's registrar is Kfin Technologies Limited and the book-running lead manager(s) for this rights issue have not yet been disclosed. 

FAQs

1. What are the details of the Mahindra & Mahindra Rights Issue?

Mahindra & Mahindra Rights Issue details are as follows: Mahindra & Mahindra plans to issue 15,44,41,240 equity shares amounting to Rs 2,996.16 crores. Mahindra & Mahindra Rights issue price is Rs 194 per share, and the face value is Rs 2 per share. The rights issue entitlement ratio is 1:8, which is 1 Rights Equity Share(s) for every 8 fully paid-up equity share(s).

2. Mahindra & Mahindra Rights Issue open date and close date?

Mahindra & Mahindra Rights Issue's open date is May 22, 2025, and the closing date is June 6, 2025. Mahindra & Mahindra Rights Issue record date is May 14, 2025. The last date to buy shares of Mahindra & Mahindra is May 13, 2025.

3. How can I apply for the Mahindra & Mahindra Rights Issue?

You can apply for Mahindra & Mahindra in two ways: one is Net Banking (ASBA), and the other is by visiting the Registrar's Website (R-WAP Facility).

4. What is the entitlement ratio for the Mahindra & Mahindra Rights Issue?

Mahindra & Mahindra rights issue entitlement ratio is 1:8, which is 1 Rights Equity Share(s) for every 8 fully paid-up equity share(s).

5. How can I check the Mahindra & Mahindra Issue Allotment Status?

The registrar for this upcoming rights issue is Kfin Technologies Limited. Investors can check the allotment status by visiting the registrar's website.

6. From where can I get the Letter of Offer Mahindra & Mahindra Rights issue?

You can download the Mahindra & Mahindra Rights issue Letter of Offer by visiting here.

7. What is the listing date of the Mahindra & Mahindra Rights Issue?

The Mahindra & Mahindra Rights Issue listing date is June 11, 2025. However, the listing will be on the BSE and NSE.

8. Who are the registrar and lead managers of the Mahindra & Mahindra Rights Issue?

Mahindra & Mahindra Limited's registrar is Kfin Technologies Limited and the book-running lead manager(s) for this rights issue have not yet been disclosed.

Also Read | Lloyds Engineering Works Rights Issue Details, Record Date, Issue Price, Subscription